There are different treatment pathways for patients with a category A and course B CPS and for patients with a category C CPS. Also, the authors provide an algorithmic method of these agents during the transplant population, specializing in 1st line usage of glucagon-like peptide 1 (GLP-1) agonists because https://glp-1sideeffects82591.full-design.com/how-much-you-need-to-expect-you-ll-pay-for-a-good-stdie-glp-1-patches-79155045